analyst
IB
NASDAQ · IBIO
iBio, Inc.
Healthcare · Biotechnology
$1.45
Down-$0.00 (-0.34%)
Updated Aug 19, 2026, 2:06 PM
SID Score
4.7/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 39.67M
- P/E ratio
- -6.32
- Dividend yield
- 0.00%
- 52-week range
- $0.67 – $3.82
- Volume
- 2.79M
- Avg. volume
- 6.77M
Price performance
IBIO price history
1M range · 21 trading sessions · Daily adjusted prices
IBIO closed at $1.45 after 21 trading sessions, up 2.84% for the selected period.
- Last close
- $1.45
- Period change
- +2.84%
- Period low
- $1.36
- Period high
- $1.47
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 18, 2026 | $1.45 | $1.47 | $1.40 | $1.45 | 2.79M |
| Aug 17, 2026 | $1.45 | $1.475 | $1.4226 | $1.45 | 589.28K |
| Aug 14, 2026 | $1.38 | $1.44 | $1.34 | $1.43 | 522.57K |
| Aug 13, 2026 | $1.48 | $1.48 | $1.38 | $1.40 | 507.81K |
| Aug 12, 2026 | $1.47 | $1.54 | $1.455 | $1.47 | 599.65K |
| Aug 11, 2026 | $1.41 | $1.505 | $1.37 | $1.47 | 375.07K |
| Aug 10, 2026 | $1.41 | $1.43 | $1.39 | $1.40 | 479.12K |
| Aug 7, 2026 | $1.40 | $1.425 | $1.375 | $1.41 | 436.39K |
| Aug 6, 2026 | $1.40 | $1.4119 | $1.36 | $1.39 | 424.31K |
| Aug 5, 2026 | $1.46 | $1.48 | $1.39 | $1.40 | 304.81K |
| Aug 4, 2026 | $1.46 | $1.49 | $1.44 | $1.46 | 486.24K |
| Aug 3, 2026 | $1.44 | $1.44 | $1.38 | $1.42 | 470.29K |
| Jul 31, 2026 | $1.41 | $1.47 | $1.34 | $1.40 | 728.59K |
| Jul 30, 2026 | $1.36 | $1.415 | $1.35 | $1.39 | 422.4K |
| Jul 29, 2026 | $1.39 | $1.41 | $1.29 | $1.36 | 802.9K |
| Jul 28, 2026 | $1.45 | $1.45 | $1.33 | $1.39 | 1.01M |
| Jul 27, 2026 | $1.44 | $1.47 | $1.35 | $1.45 | 1.05M |
| Jul 24, 2026 | $1.40 | $1.465 | $1.31 | $1.43 | 1.21M |
| Jul 23, 2026 | $1.35 | $1.41 | $1.33 | $1.40 | 464.67K |
| Jul 22, 2026 | $1.40 | $1.4073 | $1.35 | $1.38 | 370.36K |
| Jul 21, 2026 | $1.38 | $1.42 | $1.35 | $1.41 | 384.73K |
Latest IBIO news
The latest Smart Investors Daily articles mentioning IBIO.
Stock researchCompany · Financials
Loading stock research…